Atom Investors’s Bausch Health BHC Stock Holding History

Atom Investors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-106,751	Closed	-$1.66M	–	384
2020 Q3	$1.66M	Buy	+106,751	New	+$1.84M	0.16%	149
2020 Q1	–	Sell	-97,796	Closed	-$2.93M	–	319
2019 Q4	$2.93M	Sell	97,796 -252,204	-72%	-$6.56M	0.24%	111
2019 Q3	$7.65M	Buy	350,000 +100,000	+40%	+$2.29M	0.52%	61
2019 Q2	$6.3M	Buy	+250,000	New	+$5.94M	0.41%	80

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Atom Investors's BHC Position: Q4 2020 in Review

Atom Investors sold out of Bausch Health (BHC) in Q4 2020, closing a stake of 106,751 shares — an estimated $1.66M sold.

Atom Investors first reported a position in BHC in Q2 2019 and held it in 4 quarters. The position peaked at $7.65M in Q3 2019. 338 funds tracked by Wall St. Rank hold BHC as of Q4 2020.

Atom Investors reported no remaining Bausch Health position as of Q4 2020 after selling out during the quarter.
Atom Investors sold 106,751 Bausch Health shares in Q4 2020, an estimated $1.66M.
Atom Investors first reported a position in Bausch Health in Q2 2019 and held it in 4 quarters.
Atom Investors's Bausch Health position peaked at $7.65M in Q3 2019.
338 funds tracked by Wall St. Rank held Bausch Health as of Q4 2020.

Based on Atom Investors's 13F filing for Q4 2020, filed 16 Feb 2021.